Yahoo Web Search

    • Does Vaxart Deserve a Place in Your Portfolio?

      Entrepreneur via Yahoo Finance· 4 days ago

      Biotechnology company Vaxart, Inc. (VXRT) develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The price of its...

    • Is Vaxart a Buy?

      Motley Fool· 5 days ago

      In the early days of the pandemic, Vaxart (NASDAQ: VXRT) mesmerized investors after beginning development of a tablet-based, room-temperature-stable...